celecoxib has been researched along with Dermatitis in 7 studies
Dermatitis: Any inflammation of the skin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, XT | 1 |
| Mou, XQ | 1 |
| Xi, QM | 1 |
| Liu, WT | 1 |
| Liu, WF | 1 |
| Sheng, ZJ | 1 |
| Zheng, X | 1 |
| Zhang, K | 1 |
| Du, ZY | 1 |
| Zhao, SQ | 1 |
| Wang, SH | 1 |
| Quiñones, OG | 1 |
| Pierre, MBR | 1 |
| Sawamura, S | 1 |
| Kajihara, I | 1 |
| Ihn, H | 1 |
| Liu, TP | 1 |
| Chen, YP | 1 |
| Chou, CM | 1 |
| Chiu, TT | 1 |
| Chen, CT | 1 |
| Wilgus, TA | 3 |
| Koki, AT | 1 |
| Zweifel, BS | 1 |
| Kusewitt, DF | 2 |
| Rubal, PA | 1 |
| Oberyszyn, TM | 3 |
| Tober, KL | 1 |
| Thomas-Ahner, JM | 1 |
| Maruyama, T | 1 |
| Ross, MS | 1 |
| Parrett, ML | 1 |
1 review available for celecoxib and Dermatitis
| Article | Year |
|---|---|
Cutaneous Application of Celecoxib for Inflammatory and Cancer Diseases.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygena | 2019 |
6 other studies available for celecoxib and Dermatitis
| Article | Year |
|---|---|
Anti-inflammatory activity effect of 2-substituted-1,4,5,6-tetrahydrocyclopenta[b]pyrrole on TPA-induced skin inflammation in mice.
Topics: Animals; Anti-Inflammatory Agents; Cyclopentanes; Dermatitis; Mice; NF-kappa B; Pyrroles; Tetradecan | 2016 |
A case of scleroderma associated with interstitial neutrophilic granulomatous reaction.
Topics: Administration, Oral; Adult; Biopsy, Needle; Celecoxib; Dermatitis; Female; Granuloma; Humans; Immun | 2019 |
Therapeutic evaluation of HIV transduction basic domain-conjugated superoxide dismutase solution on suppressive effects of the formation of peroxynitrite and expression of COX-2 in murine skin.
Topics: Animals; Celecoxib; Cyclooxygenase 2; Dermatitis; Gene Expression Regulation, Enzymologic; Humans; M | 2016 |
Inhibition of cutaneous ultraviolet light B-mediated inflammation and tumor formation with topical celecoxib treatment.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; | 2003 |
Importance of the EP(1) receptor in cutaneous UVB-induced inflammation and tumor development.
Topics: Animals; Celecoxib; Cinnamates; Cyclooxygenase Inhibitors; Dermatitis; Female; Keratinocytes; Mice; | 2006 |
Topical application of a selective cyclooxygenase inhibitor suppresses UVB mediated cutaneous inflammation.
Topics: Administration, Topical; Animals; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxy | 2000 |